199 related articles for article (PubMed ID: 31496651)
1. Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats.
Zheng RH; Bai XJ; Zhang WW; Wang J; Bai F; Yan CP; James EA; Bose HS; Wang NP; Zhao ZQ
Drug Des Devel Ther; 2019; 13():2745-2757. PubMed ID: 31496651
[TBL] [Abstract][Full Text] [Related]
2. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
[TBL] [Abstract][Full Text] [Related]
3. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart.
Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ
Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830
[TBL] [Abstract][Full Text] [Related]
4. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
5. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats.
Bai F; Zhang LH; Zhang WW; Zheng RH; Eskew JR; Bennett J; Wang NP; Bose HS; Zhao ZQ
Eur J Pharmacol; 2020 Jan; 867():172844. PubMed ID: 31811859
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels.
Bai XJ; Hao JT; Zheng RH; Yan CP; Wang J; Yang CH; Zhang WF; Zhao ZQ
Cardiovasc Drugs Ther; 2021 Feb; 35(1):87-101. PubMed ID: 33057968
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
[TBL] [Abstract][Full Text] [Related]
8. Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension.
Banks TE; Rajapaksha M; Zhang LH; Bai F; Wang NP; Zhao ZQ
Eur J Pharmacol; 2022 Jul; 927():175048. PubMed ID: 35644422
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
10. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats.
Pang XF; Zhang LH; Bai F; Wang NP; Garner RE; McKallip RJ; Zhao ZQ
Drug Des Devel Ther; 2015; 9():6043-54. PubMed ID: 26648693
[TBL] [Abstract][Full Text] [Related]
13. MG132 treatment attenuates cardiac remodeling and dysfunction following aortic banding in rats via the NF-κB/TGFβ1 pathway.
Ma Y; Chen B; Liu D; Yang Y; Xiong Z; Zeng J; Dong Y
Biochem Pharmacol; 2011 May; 81(10):1228-36. PubMed ID: 21420391
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.
Chen P; Yang F; Wang W; Li X; Liu D; Zhang Y; Yin G; Lv F; Guo Z; Mehta JL; Wang X
J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):179-188. PubMed ID: 32686479
[TBL] [Abstract][Full Text] [Related]
15. Steroidogenic acute regulatory protein/aldosterone synthase mediates angiotensin II-induced cardiac fibrosis and hypertrophy.
Zhang WW; Zheng RH; Bai F; Sturdivant K; Wang NP; James EA; Bose HS; Zhao ZQ
Mol Biol Rep; 2020 Feb; 47(2):1207-1222. PubMed ID: 31820314
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.
Kyhl K; Lønborg J; Hartmann B; Kissow H; Poulsen SS; Ali HE; Kjær A; Dela F; Engstrøm T; Treiman M
Peptides; 2017 Jul; 93():1-12. PubMed ID: 28460895
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis.
Bai F; Pang XF; Zhang LH; Wang NP; McKallip RJ; Garner RE; Zhao ZQ
Life Sci; 2016 May; 153():141-52. PubMed ID: 27085217
[TBL] [Abstract][Full Text] [Related]
18. Dietary nitrite supplementation attenuates cardiac remodeling in l-NAME-induced hypertensive rats.
Sonoda K; Ohtake K; Uchida H; Ito J; Uchida M; Natsume H; Tamada H; Kobayashi J
Nitric Oxide; 2017 Jul; 67():1-9. PubMed ID: 28438687
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II.
Wang NP; Erskine J; Zhang WW; Zheng RH; Zhang LH; Duron G; Gendreau J; Zhao ZQ
J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317706653. PubMed ID: 28490219
[TBL] [Abstract][Full Text] [Related]
20. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
